Skip to main content

Peer Review reports

From: Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

Original Submission
18 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 Mar 2023 Reviewed Reviewer Report
17 Mar 2023 Reviewed Reviewer Report
22 Mar 2023 Author responded Author comments - Zhe Wang
Resubmission - Version 3
22 Mar 2023 Submitted Manuscript version 3
23 Mar 2023 Author responded Author comments - Zhe Wang
Resubmission - Version 4
23 Mar 2023 Submitted Manuscript version 4
28 Mar 2023 Reviewed Reviewer Report
29 Mar 2023 Author responded Author comments - Zhe Wang
29 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 5
29 Mar 2023 Submitted Manuscript version 5
1 Apr 2023 Reviewed Reviewer Report
7 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
8 Apr 2023 Editorially accepted
18 Apr 2023 Article published 10.1186/s12885-023-10828-z

You can find further information about peer review here.

Back to article page